Myopathy News and Research

RSS
The myopathies are neuromuscular disorders in which the primary symptom is muscle weakness due to dysfunction of muscle fiber. Other symptoms of myopathy can include include muscle cramps, stiffness, and spasm. Myopathies can be inherited (such as the muscular dystrophies) or acquired (such as common muscle cramps).
Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

Health supplement hope for child muscle disease

Health supplement hope for child muscle disease

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Merck announces results from ISENTRESS Phase III combination study on HIV-1

AANEM Foundation strengthens and expands research initiatives

AANEM Foundation strengthens and expands research initiatives

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Oral steroid users twice as likely to have severe vitamin D deficiency

Oral steroid users twice as likely to have severe vitamin D deficiency

New treatment strategy for dominant forms of muscular dystrophy

New treatment strategy for dominant forms of muscular dystrophy

Colchicine more effective than placebo for recurrent pericarditis

Colchicine more effective than placebo for recurrent pericarditis

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Positive results from etanercept pilot study against dermatomyositis

Positive results from etanercept pilot study against dermatomyositis

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

U.S. FDA announces safety label changes for cholesterol-lowering medication, simvastatin

U.S. FDA announces safety label changes for cholesterol-lowering medication, simvastatin

RRD enters partnership with NIH Therapeutics for Rare and Neglected Diseases program

RRD enters partnership with NIH Therapeutics for Rare and Neglected Diseases program

New research finds pattern for detecting 'false-positive' ANA results

New research finds pattern for detecting 'false-positive' ANA results

UAB researchers pinpoint protein that causes nephrotic syndrome

UAB researchers pinpoint protein that causes nephrotic syndrome

Research finds alteration in KBTBD13 protein causes nemaline myopathy

Research finds alteration in KBTBD13 protein causes nemaline myopathy

Merck announces initial results from ISENTRESS Phase III study in HIV-1

Merck announces initial results from ISENTRESS Phase III study in HIV-1

VYTORIN reduces major vascular events in patients with chronic kidney disease

VYTORIN reduces major vascular events in patients with chronic kidney disease

Immunosuppressive therapy benefits necrotizing myopathy patients with novel autoantibody specificity

Immunosuppressive therapy benefits necrotizing myopathy patients with novel autoantibody specificity